Gland Pharma Q1 net surges 47% to ₹317 cr on higher revenue
Summary
- Gland Pharma's Q1 net profit has increased by 47% to ₹317 cr
- The growth is driven by recent product launches from the CDMO portfolio
- Strong customer demand has also contributed to the revenue increase
Key Facts
- · Gland Pharma's Q1 net profit is ₹317 cr
- · 47% increase in Q1 net profit
- · Recent product launches from CDMO portfolio drove growth
- · Strong customer demand contributed to revenue increase
Why it matters
This development indicates a positive trend in the pharmaceutical industry, driven by product innovation and customer demand.
#Gland Pharma#pharmaceutical industry#Q1 results#revenue growth